The federal committee, which launched its inquiry in late 2025, is assessing the accessibility, pricing, and regulation of ...
A biotech specialist doubled down on Dyne ahead of a clinical readout that drew up investor fanfare — and the timing may be ...
This fabless semiconductor innovator specializing in GaN power ICs saw a key insider reduce direct holdings, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback